NasdaqGS - Delayed Quote USD

Alignment Healthcare, Inc. (ALHC)

5.18 +0.17 (+3.39%)
At close: April 23 at 4:00 PM EDT
5.24 +0.06 (+1.16%)
Pre-Market: 7:09 AM EDT
Loading Chart for ALHC
DELL
  • Previous Close 5.01
  • Open 5.00
  • Bid 5.13 x 300
  • Ask 5.19 x 600
  • Day's Range 4.91 - 5.19
  • 52 Week Range 4.46 - 9.20
  • Volume 803,750
  • Avg. Volume 923,830
  • Market Cap (intraday) 978.906M
  • Beta (5Y Monthly) 1.30
  • PE Ratio (TTM) --
  • EPS (TTM) -0.79
  • Earnings Date May 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.90

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

www.alignmenthealth.com

1,536

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALHC

Performance Overview: ALHC

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALHC
39.84%
S&P 500
6.30%

1-Year Return

ALHC
2.63%
S&P 500
22.67%

3-Year Return

ALHC
77.48%
S&P 500
22.63%

5-Year Return

ALHC
--
S&P 500
27.58%

Compare To: ALHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALHC

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    977.01M

  • Enterprise Value

    828.98M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.53

  • Price/Book (mrq)

    6.23

  • Enterprise Value/Revenue

    0.45

  • Enterprise Value/EBITDA

    -7.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.12%

  • Return on Assets (ttm)

    -12.84%

  • Return on Equity (ttm)

    -74.58%

  • Revenue (ttm)

    1.82B

  • Net Income Avi to Common (ttm)

    -148.02M

  • Diluted EPS (ttm)

    -0.79

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    318.82M

  • Total Debt/Equity (mrq)

    109.13%

  • Levered Free Cash Flow (ttm)

    -149.55M

Research Analysis: ALHC

Analyst Price Targets

4.50
7.90 Average
5.18 Current
10.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: ALHC

Fair Value

5.18 Current
 

Dividend Score

0 Low
ALHC
Sector Avg.
100 High
 

Hiring Score

0 Low
ALHC
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
ALHC
Sector Avg.
100 High
 

People Also Watch